These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 1132076)

  • 21. Failure of renin suppression by angiotensin II in hypertension.
    Williams GH; Hollenberg NK; Moore TJ; Dluhy RG; Bavli SZ; Solomon HS; Mersey JH
    Circ Res; 1978 Jan; 42(1):46-52. PubMed ID: 618602
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Simultaneous measurement of renin and renin substrate concentration in human plasma by a simple kinetic method.
    Campillo JE; Garcia Del Rio C; Quesada T; Osorio C
    Clin Chim Acta; 1976 Dec; 73(3):475-9. PubMed ID: 1000866
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Results of radioimmunologic determination of renin activity and the concentration of angiotensin II in the plasma of hypertensive patients].
    Serebrovskaia IuA; Ustinova SE
    Kardiologiia; 1976 Nov; 16(11):70-7. PubMed ID: 1011470
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Radioimmunoassay of plasma renin activity.
    Sealey JE; Laragh JH
    Semin Nucl Med; 1975 Apr; 5(2):189-202. PubMed ID: 164697
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Renin reactivity, renin activity and renin concentration in patients with normal and low renin essential hypertension.
    McDonald WJ; Cohen EL; Conn JW
    J Clin Endocrinol Metab; 1977 Oct; 45(4):685-90. PubMed ID: 914973
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Behavior of intradialysis curves of the PRA (Plasma Renin Activity) in a group of uremic patients during a periodic hemodialysis treatment].
    Farinelli A; Bagni B; Squerzanti R; Candini GC; Gilli P
    Minerva Nefrol; 1973; 20(6):376-89. PubMed ID: 4366348
    [No Abstract]   [Full Text] [Related]  

  • 27. Genetic influence on the renin-angiotensin system. Evidence for a renin inhibitor in hypertension-prone rats.
    Iwai J; Knudsen KD; Dahl LK
    J Exp Med; 1970 Mar; 131(3):543-57. PubMed ID: 4312940
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Beta-adrenergic receptor blockade as a therapeutic approach for suppressing the renin-angiotensin-aldosterone system in normotensive and hypertensive subjects.
    Blumenfeld JD; Sealey JE; Mann SJ; Bragat A; Marion R; Pecker MS; Sotelo J; August P; Pickering TG; Laragh JH
    Am J Hypertens; 1999 May; 12(5):451-9. PubMed ID: 10342782
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Platelet angiotensin II binding and plasma renin concentration, plasma renin substrate and plasma angiotensin II in human pregnancy.
    Baker PN; Broughton Pipkin F; Symonds EM
    Clin Sci (Lond); 1990 Oct; 79(4):403-8. PubMed ID: 2171863
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Plasma renin activity and angiotensin I and aldosterone concentrations in cats with hypertension associated with chronic renal disease.
    Jensen J; Henik RA; Brownfield M; Armstrong J
    Am J Vet Res; 1997 May; 58(5):535-40. PubMed ID: 9140564
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Angiotensinogen depletion by high renin levels in hypertensive rats: no evidence for tonic stimulation of angiotensinogen by angiotensin II.
    Gahnem F; Camargo MJ; von Lutterotti N; Laragh JH; Sealey JE
    J Hypertens; 1995 Jan; 13(1):91-6. PubMed ID: 7759857
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Studies of the renin-renin substrate reaction in man; kinetic evidence for inhibition by serum.
    Craig M; Sullivan JM; Saravis CA; Hickler RB
    Am J Med Sci; 1977; 274(1):45-54. PubMed ID: 900155
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Blood pressure and renin-angiotensin system resetting in transgenic rats with elevated plasma Val5-angiotensinogen.
    Bohlender J; Bader M; Ménard J; Nussberger J
    J Hypertens; 2012 Aug; 30(8):1597-605. PubMed ID: 22728903
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Renin inhibitory effect of synthetic phosphorylethanolamine (PE-104) in the rat.
    Miyazaki M; Yamamoto K; Hosoki K
    Clin Sci Mol Med Suppl; 1976 Dec; 3():89s-91s. PubMed ID: 1071718
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Studies of the renin-angiotension-aldosterone system, cortisol, DOC, and ADH in normal and hypertensive pregnancy.
    Weir RJ; Doig A; Fraser R; Morton JJ; Parboosingh J; Robertson JI; Wilson A
    Perspect Nephrol Hypertens; 1976; 5():251-61. PubMed ID: 1005039
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A plasma inhibitor of the renin-antirenin reaction and the in vitro generation of angiotensin I.
    Lucas CP; Waldhausl WK; Cohen EL; Berlinger FG; McDonald WJ; Sider RS
    Metabolism; 1975 Feb; 24(2):127-38. PubMed ID: 163425
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Simultaneous measurement of PRA, PRC and PRR and the relation of renin reaction rate to renin substrate concentration.
    Gordon DB; Sachin IN
    Clin Exp Hypertens (1978); 1980; 2(1):65-87. PubMed ID: 6998679
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Measurement of plasma renin activity as a valid estimation of plasma angiotensin status.
    Roulston JE; Macgregor GA; Adam T; Markandu ND
    Ann Clin Biochem; 1978 Sep; 15(5):250-2. PubMed ID: 718108
    [TBL] [Abstract][Full Text] [Related]  

  • 39. In vitro inhibition of renin by human des-angiotensin I renin substrate.
    Barrett JD; Eggena P; Hidaka H; Sambhi MP
    J Clin Endocrinol Metab; 1979 Jan; 48(1):96-100. PubMed ID: 422710
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Oral contraceptives--induced hypertension--nine years later.
    Laragh JH
    Am J Obstet Gynecol; 1976 Sep; 126(1):141-7. PubMed ID: 961741
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.